Dana-Farber Study Highlights the Need for Faster, More Accurate Diagnosis of Rare Cancer

A new study from Dana-Farber Cancer Institute finds that patients with NUT carcinoma (NC), an aggressive squamous cell lung or head and neck cancer, often face delays in diagnosis—delays that can prevent them from receiving the right treatment or joining clinical trials.

• December 8, 2025

• 3 min

• Dana-Farber